Zobrazeno 1 - 10
of 1 645
pro vyhledávání: '"P. AMBROSETTI"'
Autor:
Mohamad, Mohamad, Ponzio, Francesco, Di Cataldo, Santa, Ambrosetti, Damien, Descombes, Xavier
Renal Cell Carcinoma is typically asymptomatic at the early stages for many patients. This leads to a late diagnosis of the tumor, where the curability likelihood is lower, and makes the mortality rate of Renal Cell Carcinoma high, with respect to it
Externí odkaz:
http://arxiv.org/abs/2411.09471
Recently we investigated from first principles screening properties in systems where small molecules, characterized by a finite electronic dipole moment, are encapsulated into different nanocages. The most relevant result was the observation of an an
Externí odkaz:
http://arxiv.org/abs/2405.18864
Publikováno v:
Physical Review Letters 31, 206301 (2023)
Superfluidity is a well-characterized quantum phenomenon which entails frictionless-motion of mesoscopic particles through a superfluid, such as $^4$He or dilute atomic-gases at very low temperatures. As shown by Landau, the incompatibility between e
Externí odkaz:
http://arxiv.org/abs/2310.07476
Autor:
Vincenzo Rizza, Lara Tondi, Angelo Maria Patti, Damiano Cecchi, Massimo Lombardi, Francesco Perone, Marco Ambrosetti, Manfredi Rizzo, Domenico Cianflone, Francesco Maranta
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 23, Iss , Pp 200338- (2024)
Diabetes mellitus (DM) is one of the most prevalent cardiovascular risk factors in the general population, being associated with high morbidity and socioeconomic burden. Diabetic cardiomyopathy (DCM) is a non-negligible complication of DM, whose path
Externí odkaz:
https://doaj.org/article/36e7c01bcbcd41fe9914233c1f2266fc
Autor:
Francesco Perone, Luigi Spadafora, Alessandra Pratesi, Giulia Nicolaio, Barbara Pala, Giulia Franco, Matteo Ruzzolini, Marco Ambrosetti
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 23, Iss , Pp 200331- (2024)
The patient with obesity is at risk of developing cardiovascular disease and risk factors. Obesity negatively impacts prognosis and increases cardiovascular morbidity and mortality. Therefore, a comprehensive risk assessment is needed to define the c
Externí odkaz:
https://doaj.org/article/027e83874cf44f46959ccb461b2a7b8b
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 23, Iss , Pp 200335- (2024)
Externí odkaz:
https://doaj.org/article/d8d2e0368c05414b8ec15fb6af994ea4
We investigate from first principles screening effects in endohedral complexes when small molecules, characterized by a finite electronic dipole moment, such as HF, LiF, NaCl, and H$_2$O, are encapsulated into different nanoscale cages. We find that
Externí odkaz:
http://arxiv.org/abs/2210.05324
Water-flow in carbon nanotubes (CNT's) starkly contradicts classical fluid mechanics, with permeabilities that can exceed no-slip Haagen-Poiseuille predictions by two to five orders of magnitude. Semi-classical molecular dynamics accounts for enhance
Externí odkaz:
http://arxiv.org/abs/2207.12865
Autor:
Gian Francesco Mureddu, Paola D'Errigo, Stefano Rosato, Pompilio Faggiano, Gabriella Badoni, Roberto Ceravolo, Vito Altamura, Mirko Di Martino, Marco Ambrosetti, Fabrizio Oliva, Paola Ciccarelli, Giovanni Baglio
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 22, Iss , Pp 200310- (2024)
Background: The reduction in long-term mortality after acute myocardial infarction (AMI) is less pronounced than that of in-hospital mortality among patients with AMI complicated by heart failure (HF) and/or in those with a high residual thrombotic r
Externí odkaz:
https://doaj.org/article/c1939ce6afa348ffb72f5f19f8da5e94
Autor:
Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, Olivia Rastoin, Rosie Dawaliby, Thomas Schmitt, Maxence Bourgoin, Héliciane Palenzuela, Anne-Laure Rossi, Damien Ambrosetti, Jerome Durivault, Frederic Luciano, Delphine Borchiellini, Julie Le Du, Leticia Christina Pires Gonçalves, Patrick Auberger, Rachid Benhida, Lisa Kinget, Benoit Beuselinck, Cyril Ronco, Gilles Pagès, Maeva Dufies
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)
Abstract Background In clear cell renal cell carcinoma (ccRCC), first-line treatment combines nivolumab (anti-PD-1) and ipilimumab (anti-CTLA4), yielding long-term remissions but with only a 40% success rate. Our study explored the potential of enhan
Externí odkaz:
https://doaj.org/article/2ff8f539d4e9454cb864905303b22e6e